BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15354402)

  • 1. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
    Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
    J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical surgery does not recover immunodeficiency associated with gastric cancer.
    Romano F; Caprotti R; Bravo AF; Conti M; Colombo G; Piacentini G; Uggeri F; Uggeri F
    J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
    Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
    Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of hypothalamus-pituitary-adrenal gland axis in colorectal cancer patients. Preliminary report.
    Crippa S; Mussi C; Angelini C; Caprotti R; Bonardi C; Muselli P; Scotti M; Piacentini G; Uggeri F
    Minerva Chir; 2003 Aug; 58(4):581-5. PubMed ID: 14603172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
    Franciosi CM; Piacentini MG; Conti M; Romano F; Musco F; Caprotti R; Rovelli F; Uggeri F
    Hepatogastroenterology; 2003; 50(49):297-300. PubMed ID: 12630045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial.
    Li Y; Yang GL; Yuan HY; Bai DJ; Wang K; Lin CR; Hu MB; Feng MH
    Hepatogastroenterology; 2005; 52(62):504-8. PubMed ID: 15816467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term preoperative IL-2 immunotherapy in operable pancreatic cancer: a randomized study.
    Uggeri F; Caprotti R; De Grate L; Crippa S; Nobili C; Penati C; Romano F
    Hepatogastroenterology; 2009; 56(91-92):861-5. PubMed ID: 19621718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic resection induces a shift in the Th 1/2 balance toward Th 2 and produces hypermetabolic and hyperhemodynamic states.
    Ishikawa M; Nishioka M; Hanaki N; Miyauchi T; Kashiwagi Y; Miki H
    Hepatogastroenterology; 2004; 51(59):1422-7. PubMed ID: 15362768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
    Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
    Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression.
    Brivio F; Gilardi R; Bucocev R; Ferrante R; Rescaldani R; Vigoré L; Fumagalli L; Nespoli A; Lissoni P
    Hepatogastroenterology; 2000; 47(35):1337-9. PubMed ID: 11100346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of a method of reconstruction after pancreatoduodenectomy.
    Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
    Hepatogastroenterology; 2005; 52(64):1077-82. PubMed ID: 16001633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.
    Cerea K; Romano F; Bravo AF; Motta V; Uggeri F; Brivio F; Fumagalli LA; Uggeri F
    J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.